Grifols reported EUR10.67B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
aTyr Pharma USD 398K 204K Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 10.67B 564.4M Sep/2025